The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Insulin Delivery Devices Market Projected To Reach By 2030?
The insulin delivery devices market size has experienced robust growth in recent years. It is forecast to increase from $19.07 billion in 2025 to $20.61 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.1%. This historical expansion can be attributed to the rising prevalence of diabetes, growing awareness of diabetes management, increased availability of insulin therapies, expansion of healthcare access, and rising adoption of self-injection practices.
The insulin delivery devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $28.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period stems from factors such as a rising worldwide diabetic population, an escalating need for user-friendly insulin administration techniques, a heightened emphasis on managing diabetes over the long term, broader availability of diabetes treatment in developing economies, and increased uptake of home-based healthcare options. Key trends projected for this period involve a greater shift towards insulin pens instead of conventional syringes, an increasing requirement for insulin pumps for uninterrupted insulin supply, a growing preference for easy-to-use and portable insulin equipment, the expansion of diabetes management solutions within the home environment, and a wider deployment of disposable and pre-filled insulin delivery units.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp
Which Major Drivers Are Influencing The Expansion Of The Insulin Delivery Devices Market?
The increasing occurrence of diabetes is anticipated to drive the expansion of the insulin delivery devices market in the future. This chronic ailment is characterized by elevated blood sugar levels, stemming from either insufficient insulin generation by the pancreas or the body’s impaired capacity to use insulin properly. The escalation in diabetes cases is predominantly attributed to factors like inactive lifestyles, poor dietary habits, and a global surge in obesity. Insulin delivery devices are essential for individuals with diabetes to efficiently regulate their blood sugar levels through precise and user-friendly insulin administration, thus averting health complications and fostering well-being. As an illustration, the International Diabetes Federation, a Belgium-based non-governmental organization, reported that in 2024, approximately 589 million adults aged 20–79 globally are afflicted with diabetes. This figure is forecasted to climb to 853 million by 2050. Consequently, the expanding incidence of diabetes is fueling the development of the insulin delivery devices market.
How Is The Insulin Delivery Devices Market Broken Down By Segment Categories?
The insulin delivery devices market covered in this report is segmented –
1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens
2) By Disease Indication: Type 1, Type 2
3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers
Subsegments:
1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length
2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors
3) By Pen Needles: Short Pen Needles, Long Pen Needles
4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens
5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens
Which Trends Are Shaping The Insulin Delivery Devices Market?
Leading companies within the insulin delivery devices market are developing innovative products, including insulin pumps, to provide continuous or customizable insulin delivery. These programmable medical devices deliver insulin continuously or on demand via a catheter placed subcutaneously. For instance, in May 2023, US-based medical technology company Beta Bionics announced U.S. Food and Drug Administration approval for its iLet ACE Pump and the iLet Dosing Decision Software. Aimed at individuals aged six and older with type 1 diabetes, the iLet Bionic Pancreas system integrates two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). Operating through an automated insulin dosing (AID) system powered by an adaptive closed-loop algorithm, it initially uses only the user’s body weight for setup, thereby eliminating the need for additional insulin dosing parameters. Distinguishing itself from traditional pump therapy, this system requires no manual adjustment of settings, which simplifies its initiation and management. Additionally, the iLet device incorporates a meal announcement feature, streamlining mealtime insulin dosing by categorizing meals as small, medium, or large, as the algorithm learns and adapts to individual insulin requirements over time.
Which Players Are Present In The Insulin Delivery Devices Market Space?
Major companies operating in the insulin delivery devices market are Novo Nordisk A/S, Medtronic Plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation
Get The Full Insulin Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report
Which Region Is The Leading Market For The Insulin Delivery Devices Market?
North America was the largest region in the insulin delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Insulin Delivery Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp
Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2026, By The Business Research Company
Wearable Ai Market Report 2026
https://www.thebusinessresearchcompany.com/report/wearable-ai-global-market-report
Smart Wearables Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-wearables-global-market-report
Wearable Computing Market Report 2026
https://www.thebusinessresearchcompany.com/report/wearable-computing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model